FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1989540817> ?p ?o ?g. }

• W1989540817 endingPage "19" @default.
• W1989540817 startingPage "15" @default.
• W1989540817 abstract "A series of oxicam non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to be neuroprotective against 1-methyl-4-phenyl pyridinium in human neuroblastoma SH-SY5Y cells via the phosphatidylinositol 3-kinase (PI3K)/Akt pathway independent of cyclooxygenase (COX) inhibition. The present study endeavored to establish this novel effect of meloxicam (MLX), an oxicam NSAID, in a mouse Parkinson's disease (PD) model using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Male C57BL/6 mice, which received MPTP (30 mg/kg/day; s.c.) for 5 consecutive days (chronic model) with 10-day follow-up saline administrations, showed significant motor dysfunction in the pole test due to reduced tyrosine hydroxylase (TH) protein levels in the brain on day 16 after MPTP/saline treatment. Daily coadministrations of MLX (10 mg/kg/day; i.p.) and MPTP for the first 5 days and follow-up 10 days with MLX administrations alone (MPTP/MLX treatment) significantly ameliorated MPTP-induced behavioral abnormalities in mice. Concomitant decreases of TH protein levels in the striatum and midbrain of MPTP/MLX-treated mice were not only significantly (p < 0.01 and p < 0.05, respectively) ameliorated but phosphorylated Akt (pAkt473) expression in the midbrain was also significantly (p < 0.01) increased in the midbrain when compared with MPTP/saline-treated mice. These results suggest that MLX, an oxicam NSAID, attenuated dopaminergic neuronal death in the experimental MPTP-PD model by maintenance of the Akt-signaling. Oxicam NSAIDs may serve as potential drugs for PD treatment via a novel mechanism of action." @default.
• W1989540817 created "2016-06-24" @default.
• W1989540817 creator A5000440080 @default.
• W1989540817 creator A5001273525 @default.
• W1989540817 creator A5017196987 @default.
• W1989540817 creator A5022548799 @default.
• W1989540817 creator A5038527025 @default.
• W1989540817 creator A5041551010 @default.
• W1989540817 creator A5043626693 @default.
• W1989540817 creator A5048449318 @default.
• W1989540817 creator A5050982051 @default.
• W1989540817 creator A5055974608 @default.
• W1989540817 creator A5056835579 @default.
• W1989540817 creator A5076644433 @default.
• W1989540817 creator A5086257838 @default.
• W1989540817 creator A5090538089 @default.
• W1989540817 date "2012-07-01" @default.
• W1989540817 modified "2023-10-11" @default.
• W1989540817 title "Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model" @default.
• W1989540817 cites W1964634933 @default.
• W1989540817 cites W1965156670 @default.
• W1989540817 cites W1971332616 @default.
• W1989540817 cites W1975331070 @default.
• W1989540817 cites W1980977603 @default.
• W1989540817 cites W1988091123 @default.
• W1989540817 cites W1994548914 @default.
• W1989540817 cites W1997781505 @default.
• W1989540817 cites W2000073596 @default.
• W1989540817 cites W2014571928 @default.
• W1989540817 cites W2022911097 @default.
• W1989540817 cites W2029241688 @default.
• W1989540817 cites W2041678827 @default.
• W1989540817 cites W2056365448 @default.
• W1989540817 cites W2056546282 @default.
• W1989540817 cites W2064996887 @default.
• W1989540817 cites W2084140068 @default.
• W1989540817 cites W2119140309 @default.
• W1989540817 cites W2120200579 @default.
• W1989540817 cites W2136503661 @default.
• W1989540817 cites W2144016274 @default.
• W1989540817 cites W2145731644 @default.
• W1989540817 cites W2156177559 @default.
• W1989540817 cites W2162279729 @default.
• W1989540817 cites W2315634470 @default.
• W1989540817 doi "https://doi.org/10.1016/j.neulet.2012.05.045" @default.
• W1989540817 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22617635" @default.
• W1989540817 hasPublicationYear "2012" @default.
• W1989540817 type Work @default.
• W1989540817 sameAs 1989540817 @default.
• W1989540817 citedByCount "21" @default.
• W1989540817 countsByYear W19895408172013 @default.
• W1989540817 countsByYear W19895408172014 @default.
• W1989540817 countsByYear W19895408172015 @default.
• W1989540817 countsByYear W19895408172016 @default.
• W1989540817 countsByYear W19895408172017 @default.
• W1989540817 countsByYear W19895408172018 @default.
• W1989540817 countsByYear W19895408172019 @default.
• W1989540817 countsByYear W19895408172020 @default.
• W1989540817 countsByYear W19895408172021 @default.
• W1989540817 countsByYear W19895408172022 @default.
• W1989540817 countsByYear W19895408172023 @default.
• W1989540817 crossrefType "journal-article" @default.
• W1989540817 hasAuthorship W1989540817A5000440080 @default.
• W1989540817 hasAuthorship W1989540817A5001273525 @default.
• W1989540817 hasAuthorship W1989540817A5017196987 @default.
• W1989540817 hasAuthorship W1989540817A5022548799 @default.
• W1989540817 hasAuthorship W1989540817A5038527025 @default.
• W1989540817 hasAuthorship W1989540817A5041551010 @default.
• W1989540817 hasAuthorship W1989540817A5043626693 @default.
• W1989540817 hasAuthorship W1989540817A5048449318 @default.
• W1989540817 hasAuthorship W1989540817A5050982051 @default.
• W1989540817 hasAuthorship W1989540817A5055974608 @default.
• W1989540817 hasAuthorship W1989540817A5056835579 @default.
• W1989540817 hasAuthorship W1989540817A5076644433 @default.
• W1989540817 hasAuthorship W1989540817A5086257838 @default.
• W1989540817 hasAuthorship W1989540817A5090538089 @default.
• W1989540817 hasBestOaLocation W19895408172 @default.
• W1989540817 hasConcept C11960822 @default.
• W1989540817 hasConcept C126322002 @default.
• W1989540817 hasConcept C134018914 @default.
• W1989540817 hasConcept C137183658 @default.
• W1989540817 hasConcept C159167319 @default.
• W1989540817 hasConcept C185592680 @default.
• W1989540817 hasConcept C25498285 @default.
• W1989540817 hasConcept C2778674702 @default.
• W1989540817 hasConcept C2779751750 @default.
• W1989540817 hasConcept C2780062018 @default.
• W1989540817 hasConcept C513476851 @default.
• W1989540817 hasConcept C55493867 @default.
• W1989540817 hasConcept C71924100 @default.
• W1989540817 hasConcept C75217442 @default.
• W1989540817 hasConcept C98274493 @default.
• W1989540817 hasConceptScore W1989540817C11960822 @default.
• W1989540817 hasConceptScore W1989540817C126322002 @default.
• W1989540817 hasConceptScore W1989540817C134018914 @default.
• W1989540817 hasConceptScore W1989540817C137183658 @default.
• W1989540817 hasConceptScore W1989540817C159167319 @default.
• W1989540817 hasConceptScore W1989540817C185592680 @default.

• next